The controversy surrounding the anticoagulant Xarelto is reaching a fevered pitch, and the British Medical Journal (BMJ) just added more fuel to the fire. Johnson & Johnson (J&J) subsidiary...
It’s not easy for patients to manage their risk of blood clots. Popular blood thinners come with some staggering bleeding risks and newer anticoagulants don’t have antidotes available to...
The Patient-Centered Outcomes Research Institute recently announced the approval of funding for two studies that will compare the safety and effectiveness of new types of anticoagulants compared to traditional...
David and Rebecca Rowell have filed a lawsuit against Janssen Research & Development LLC, Janssen Ortho LLC, Janssen Pharmaceuticals Inc., Bayer Healthcare Pharmaceuticals Inc. for negligent misrepresentation, fraudulent concealment,...
